Regulatory Recap: US Senate Passes Anti-Patent Thicket Bill, EU Council Debates Pharma Package
bit.ly/3Lu3O9R
English
Generics bulletin
5.2K posts
Generics bulletin
@Genericbulletin
Up-to-date commercial intelligence about business opportunities in the #global #generic #medicines and #biosimilars markets
Katılım Eylül 2010
164 Takip Edilen988 Takipçiler
Entering The GGB Awards: One Week To Go!
bit.ly/4faY0zS
English
J&J Confirms EU Stelara Biosimilars Are Imminent
bit.ly/3Sd3xfe
English
Re-Elected Von Der Leyen Sets Out EU Commission Plans For Critical Medicines Act
bit.ly/467Y8fp
English
Xbrane Inching Closer To Cimzia Biosimilar Trials With Batch Production
bit.ly/3Y9t5Of
English
Hikma Launches First US Sodium Acetate With CGT Exclusivity
bit.ly/4f57igG
English
Zydus’s ‘Transparency Failure’ Leads To Block On Indian Perjeta Biosimilar
bit.ly/4eZYzMV
English
Hyloris Replaces Leadership After Continued Transaction Woes
bit.ly/3y1d9TG
English
AI And Biosimilars: Untapped Area Full Of Potential – Or Hype?
bit.ly/3LvgqgQ
English
Biosimilars Report Bolsters IGBA’s Calls To Streamline Development Process
bit.ly/4cHq77U
English
Generics Bulletin Explains: After Humira Biosimilars, Will It Be Groundhog Day For Stelara?
bit.ly/3W74Ai8
English
UK Prices Continue To Shoot Up In June
bit.ly/4f5Xzqg
English
Fresenius Follows US Denosumab Filing With EU Acceptance
bit.ly/3LuNi9v
English
ANI Acquires Alimera Sciences To Bolster Ophthalmology Portfolio
bit.ly/3VTrNUQ
English
PBMs Hinder Access To Generics And Biosimilars, Finds FTC’s Investigation
bit.ly/4f2Zhci
English
Cipla’s Verma Succeeds Kabi US Veteran Ducker As CEO
bit.ly/3LlkOiz
English
Apotex Secures Canadian License For Loqtorzi From Coherus
bit.ly/4eRTWo5
Català
AEON Aims For Biosimilar Pathway For Lead Candidate In Cervical Dystonia
bit.ly/3LlksbE
English
South Africa Drops J&J Bedaquiline Scrutiny After Generic Market Opens Up
bit.ly/3RYDGYv
English
Celltrion’s Xolair Biosimilar Reaches UK, Following Key US Filing
bit.ly/4eQHTax
English